Lilly moves obesity drug to late-stage trials
Digest more
It’s estimated that more than 5.8 million people in the UK are living with diabetes, which is an all-time high, according to Diabetes UK ...
Eli Lilly and Company (NYSE: LLY) today announced positive results from a Phase 2 trial evaluating the safety and efficacy of ...
Eli Lilly's eloralintide cut body weight by up to 20% in a Phase 2 trial, showing strong efficacy and potential to advance ...
New research continues to show that many people meet the criteria for obesity and associated health problems, even if their ...
The MARITIME Phase 3 Chronic Weight Management Studies are Actively Enrolling, and Phase 3 Studies in People Living With Atherosclerotic Cardiovascular Disease, Heart Failure and Obstructive Sleep ...
New research reveals that one in five people with normal BMIs have hidden abdominal obesity, facing 29% higher blood pressure ...
The use of certain low-dose pulsed electromagnetic fields mimics the effects of exercise by stimulating the mitochondria.
16hon MSN
What’s Behind the Drop in US Obesity
While this coincides with an uptick in GLP-1 drug use, some experts told Newsweek they don't think they are having a major ...
Texas ranks eighth among the nation’s 50 states in obesity, according to a new WalletHub analysis of adult weight data.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback